Особенности лимфогенного метастазирования немелкоклеточного рака легкого у больных молодого возраста

NNN1 и N2 у пациентов молодого возраста составила 18,0 и 32,0%, среднего 22,9 и 11,4%, пожилого 16,4 и 11,9% соответственно (p The poor and contradictory literature data make it important and promising to define approaches to optimal treatment policy in young patients with lung cancer. We studied treatment outcomes in 1727 patients with non-small cell lung cancer undergoing surgery at the Surgical Thoracic Unit, N.. Blokhin RCRC RAMS during 1985 through 2007. Central cancer was discovered in 109 (63.7%) young patients, 575 (64.8%) middle-age patients and 322 (48.2%) elderly patients; peripheral location was found in 62 (36.3%), 313 (35.2%) and 346 (51.8%) cases, respectively. In cases with T2-3 tumors of 3.0 to 5.0 cm frequencies of N1 and N2 disease were 18.0 and 32.0% in young, 22.9 and 11.4% in middle-age, 16.4 and 11.9% in elderly patients, respectively (p